Error: Could not add to watchlist. X

AXA Framlington Biotech Fund

+ Watchlist
FRABIOA:LN
166.50
GBp
8.80
5.58%
As of 00:59:30 ET on 08/27/2015.
Fund Type
Unit Trust
52Wk Range
118.90 - 193.20
1 Yr Return
34.49%
YTD Return
11.97%
Previous Close
157.70
52Wk Range
118.90 - 193.20
1 Yr Return
34.49%
YTD Return
11.97%
Fund Type
Unit Trust
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
Global
NAV (on 08/27/2015)
166.5
Total Assets (m GBP) (on 08/27/2015)
729.579
Inception Date
11/26/2001
Last Dividend (on 03/02/2015)
-
Dividend Indicated Gross Yield
-
Fund Managers
LINDEN THOMSON
Front Load Fee
5.50%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
1.75%
Expense Ratio
1.95%
Top Fund Holdings
Name Position Value % of Fund
Celgene Corp 927.66 k 77.92 m 9.60
Gilead Sciences Inc 936.20 k 70.62 m 8.70
Biogen Inc 302.37 k 61.69 m 7.60
Amgen Inc 476.22 k 53.57 m 6.60
Alexion Pharmaceuticals Inc 398.26 k 50.33 m 6.20
Illumina Inc 266.03 k 37.34 m 4.60
Vertex Pharmaceuticals Inc 394.58 k 34.09 m 4.20
Regeneron Pharmaceuticals Inc 93.92 k 33.28 m 4.10
BioMarin Pharmaceutical Inc 320.82 k 30.03 m 3.70
Incyte Corp 364.87 k 24.35 m 3.00
Profile
AXA Framlington Biotech Fund is an authorized unit trust incorporated in the United Kingdom. The aim of the Fund is to provide long-term capital appreciation The Fund will invest principally in equity securities of companies in the biotechnology, genomic and medical research industries worldwide.
ADDRESS
AXA Framlington Unit Management Ltd
7 Newgate Street
London EC1A 7NX
United Kingdom
PHONE
44-207-374-4100